Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis

被引:4
作者
Rosenfeld, Margaret [1 ,2 ,12 ]
Faino, Anna, V [2 ]
Qu, Pingping [2 ]
Onchiri, Frankline M. [2 ]
Blue, Elizabeth E. [3 ]
Collaco, Joseph M. [4 ]
Gordon, William W. [5 ]
Szczesniak, Rhonda [6 ]
Zhou, Yi-Hui [7 ,8 ,9 ]
Bamshad, Michael J. [5 ,10 ,11 ]
Gibson, Ronald L. [1 ,2 ]
机构
[1] Univ Washington, Div Pulm & Sleep Med, Dept Pediat, Seattle, WA USA
[2] Seattle Childrens Res Inst, Seattle, WA USA
[3] Univ Washington, Div Med Genet, Dept Med, Seattle, WA USA
[4] Johns Hopkins Univ, Eudowood Div Pediat Resp Sci, Sch Med, Baltimore, MD USA
[5] Univ Washington, Div Genet Med, Dept Pediat, Seattle, WA USA
[6] Cincinnati Childrens Hosp & Med Ctr, Dept Pediat, Cincinnati, OH USA
[7] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA
[8] North Carolina State Univ, Dept Stat, Raleigh, NC USA
[9] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA
[10] Seattle Childrens Hosp, Seattle, WA USA
[11] Brotman Baty Inst, Seattle, WA USA
[12] Seattle Childrens Hosp, Div Pulm & Sleep Med, 4800 Sandpoint Way NE, Seattle, WA 98105 USA
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Lung function; CLINICAL EFFECTIVENESS; FUNCTION DECLINE; YOUNG-CHILDREN; RISK-FACTORS; PEOPLE; SPIROMETRY; FEV1;
D O I
10.1016/j.jcf.2023.05.004
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) is characterized in stages: never (prior to first positive culture) to incident (first positive culture) to chronic. The association of Pa infection stage with lung function trajectory is poorly understood and the impact of age on this association has not been examined. We hypothesized that FEV1 decline would be slowest prior to Pa infection, intermediate after incident infection and greatest after chronic Pa infection.Methods: Participants in a large US prospective cohort study diagnosed with CF prior to age 3 contributed data through the U.S. CF Patient Registry. Cubic spline linear mixed effects models were used to evaluate the longitudinal association of Pa stage (never, incident, chronic using 4 different definitions) with FEV1 adjusted for relevant covariates. Models contained interaction terms between age and Pa stage.Results: 1,264 subjects born 1992-2006 provided a median 9.5 (IQR 0.25 to 15.75) years of follow up through 2017. 89% developed incident Pa; 39-58% developed chronic Pa depending on the definition. Compared to never Pa, incident Pa infection was associated with greater annual FEV1 decline and chronic Pa infection with the greatest FEV1 decline. The most rapid FEV1 decline and strongest association with Pa infection stage was seen in early adolescence (ages 12-15).Conclusions: Annual FEV1 decline worsens significantly with each Pa infection stage in children with CF. Our findings suggest that measures to prevent chronic infection, particularly during the high-risk period of early adolescence, could mitigate FEV1 decline and improve survival.(c) 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 34 条
[1]  
[Anonymous], 2020, CYST FIBR FDN PAT RE
[2]  
Aurora P, 2022, J CYST FIBROS
[3]   Risk factors for lung function decline in a large cohort of young cystic fibrosis patients [J].
Cogen, Jonathan ;
Emerson, Julia ;
Sanders, Don B. ;
Ren, Clement ;
Schechter, Michael S. ;
Gibson, Ronald L. ;
Morgan, Wayne ;
Rosenfeld, Margaret .
PEDIATRIC PULMONOLOGY, 2015, 50 (08) :763-770
[4]  
Durfey SL, 2021, MBIO, V12, DOI [10.1128/mBio.03148-21, 10.1128/mbio.03148-21]
[5]   Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis [J].
Emond, Mary J. ;
Louie, Tin ;
Emerson, Julia ;
Zhao, Wei ;
Mathias, Rasika A. ;
Knowles, Michael R. ;
Wright, Fred A. ;
Rieder, Mark J. ;
Tabor, Holly K. ;
Nickerson, Deborah A. ;
Barnes, Kathleen C. ;
Go, Lung ;
Gibson, Ronald L. ;
Bamshad, Michael J. .
NATURE GENETICS, 2012, 44 (08) :886-+
[6]   Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement [J].
Graham, Brian L. ;
Steenbruggen, Irene ;
Barjaktarevic, Igor Z. ;
Cooper, Brendan G. ;
Hall, Graham L. ;
Hallstrand, Teal S. ;
Kaminsky, David A. ;
McCarthy, Kevin ;
McCormack, Meredith C. ;
Miller, Martin R. ;
Oropez, Cristine E. ;
Rosenfeld, Margaret ;
Stanojevic, Sanja ;
Swanney, Maureen P. ;
Thompson, Bruce R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (08) :E70-E88
[7]   Heritability of Respiratory Infection with Pseudomonas aeruginosa in Cystic Fibrosis [J].
Green, Deanna M. ;
Collaco, J. Michael ;
McDougal, Kathryn E. ;
Naughton, Kathleen M. ;
Blackman, Scott M. ;
Cutting, Garry R. .
JOURNAL OF PEDIATRICS, 2012, 161 (02) :290-+
[8]   Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients [J].
Green, Deanna M. ;
McDougal, Kathryn E. ;
Blackman, Scott M. ;
Sosnay, Patrick R. ;
Henderson, Lindsay B. ;
Naughton, Kathleen M. ;
Collaco, J. Michael ;
Cutting, Garry R. .
RESPIRATORY RESEARCH, 2010, 11
[9]   The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa [J].
Greenwald, Matthew A. ;
Wolfgang, Matthew C. .
CURRENT OPINION IN PHARMACOLOGY, 2022, 65
[10]   Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation * [J].
Guimbellot, J. S. ;
Baines, A. ;
Paynter, A. ;
Heltshe, S. L. ;
VanDalfsen, J. ;
Jain, M. ;
Rowe, S. M. ;
Sagel, S. D. .
JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (02) :213-219